Glucagon-Like Peptide-1 and Exendin-4 Stimulate β-Cell Neogenesis in Streptozotocin-Treated Newborn Rats Resulting in Persistently Improved Glucose Homeostasis at Adult Age

Diabetes

Volumn 50, Issue 7, 2001, Pages 1562-1570

  Tourrel, Cécile ^a,b,c   Bailbé, Danielle ^a   Meile, Marie Jo ^a   Kergoat, Micheline ^b   Portha, Bernard ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b MERCK LIPHA   (France)

^c EUROPEAN SPACE AGENCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; INSULIN; PEPTIDE; PEPTIDE FRAGMENT; PROTEIN PRECURSOR; VENOM;

ANIMAL; APOPTOSIS; ARTICLE; BLOOD; BODY WEIGHT; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; METABOLISM; NEWBORN; ORGAN SIZE; PANCREAS ISLET; PHYSIOLOGY; RAT; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; INSULIN; ISLETS OF LANGERHANS; ORGAN SIZE; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN PRECURSORS; RATS; RATS, WISTAR; VENOMS;

EID: 0035405821     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.7.1562     Document Type: Article

References (51)

1. Klöppel G, Löhr M, Habish K, Oberholzer M, Heitz PU: Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 4:110-125, 1985
2. Swenne I: Pancreatic β-cell growth and diabetes mellitus. Diabetologia 35:193-201, 1992
3. Portha B, Levacher C, Picon L, Rosselin G: Diabetogenic effect of streptozotocin in the rat during the perinatal period. Diabetes 23:889-895, 1974
4. Portha B, Blondel O, Serradas P, McEvoy R, Giroix MH, Kergoat M, Bailbe: The rat models of non-insulin dependant diabetes induced by neonatal streptozotocin. Diabet Metab 15:161-175, 1989
5. Cantenys D, Portha B, Dutrillaux MC, Hollande E, Rozé C, Picon L: Histogenesis of the endocrine pancreas in newborn rats after destruction by streptozotocin. Virchows Arch B Cell Pathol Incl Mol Pathol 35:109-122, 1981
6. Wang RN, Bouwens L, Klöppel G: β-Cell proliferation in normal and streptozotocin-treated newborn rats: site, dynamics and capacity. Diabetologia 37:1088-1096, 1994
7. Dutrillaux MC, Portha B, Rozé C, Hollande E: Ultrastructural study of pancreatic β-cell regeneration in newborn rats after destruction by streptozotocin. Virchows Arch B Cell Pathol Incl Mol Pathol 39:173-185, 1982
8. Bonner-Weir S, Trent DF, Zmachinski CJ, Clore ET, Weir GC: Limited β-cell regeneration in a β-cell deficient model: studies with dexamethasone. Metabolism 30:914-918, 1981
9. Bonner-Weir S, Trent DF, Honey RN, Weir GC: responses of neonatal rat islet to streptozotocin. Diabetes 30:64-69, 1981
10. Weir GC, Leahy JL, Bonner-Weir S: Experimental reduction of the β-cell mass: implications for the pathogenesis of diabetes. Diabete Metab Rev 2:125-161, 1986
11. Kieffer TJ, Habener JF: The glucagon-like peptides. Endocr Rev 20:876-913, 1999
12. Drucker DJ: Glucagon-like peptides. Diabetes 47:159-169, 1998
13. Habener JF: The incretin notion and its relevance to diabetes. Endocrinol Metab Clin North Am 22:775-794, 1993
14. Buteau J, Roduit R, Susini S, Prentki M: Glucagon-like peptide 1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in β (INS-1) cells. Diabetologia 42:856-864, 1999
15. Edvell A, Lindstrom P: Initiation of increased pancreatic islet growth in young normoglycemic mice (Umea +/?). Endocrinology 140:778-783, 1999
16. Xu G, Stoffers DA, Habener JF, Bonner-Weir S: Exendin-4 stimulates both β-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48:2270-2276, 1999
17. Stoffers DA, Kieffer TJ, Hussain MA, Drucker DJ, Bonner-Weir S, Habener JF, Egan JM: Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes 49:741-748, 2000
18. Giroix MH, Portha B, Kergoat M, Bailbe D, Picon L: Glucose insensitivity and amino-acid hypersensitivity of insulin release in rats with non-insulin dependent diabetes: a study with the perfused pancreas. Diabetes 32:445-451, 1983
19. Yalow RS, Berson SA: Immunoassay of endogenous plasma insulin in man. J Clin Invest 39:1157-1175, 1969
20. Portha B, Picon L, Rosselin G: Chemical diabetes in the adult rats as the spontaneous evolution of neonatal diabetes. Diabetologia 17:371-377, 1979
21. Portha B, Giroix MH, Serradas P, Movassat J, Bailbe D, Kergoat M: The neonatally streptozotocin-induced (n-STZ) diabetic rats, a family of NIDDM models. In Frontiers in Diabetic Research: Animal Models of Diabetes: A Primer. Sima A, Shafrir E. Eds. Amsterdam, Hardwood Academic, 2000, p. 247-271
22. Movassat J, Saulnier C, Portha B: Insulin administration enhances growth of the β-cell mass in streptozotocin-treated newborn rats. Diabetes 46: 1445-1452, 1997
23. Mojsov S, Weir GC, Habener JF: Insulinotropin: glucagon-like peptide 1 (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79:616-619, 1987
24. Gutniak M, Orskov C, Holst JJ, Ahren B, Efendic S: Antidiabetogenic effect of glucagon like-peptide 1 (7-36) amide in normal subjects and patients with diabetes mellitus. N Engl J Med 326:1316-1322, 1992
25. Nauck MA, Heimessat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W: Preserved incretin activity of glucagon like-peptide 1 (7-36) amide but not of synthetic human gastric inhibitory polypeptide in patients with type 2 diabetes mellitus. J Clin Invest 91:301-307, 1993
26. Thorens B, Porret A, Bulher L, Deng SP, Morel P, Widmann C: Cloning and functional expression of the human islet GLP-1-receptor: demonstration that exendin-4 is an agonist and exendin (9-39) is an antagonist of the receptor. Diabetes 42:1678-1682, 1993
27. Wang Y, Perfetti R, Greig N, Holloway H, De Ore K, Montrose-Rafizadeh C, Elahi D, Egan JM: Glucagon like-peptide 1 (7-36) amide can reverse the age-related decline in glucose tolerance in rats. J Clin Invest 99:2883-2889, 1997
28. Rosenberg L: In vivo cell transformation: neogenesis of β-cells from pancreatic ductal cells. Cell Transplant 4:371-383, 1995
29. Bouwens L, Klöppel G: Islet cell neogenesis in the pancreas. Virchows Arch 427:553-560, 1996
30. Scaglia L, Cahill CJ, Finegood DT, Bonner-Weir S: Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 138:1736-1741, 1997
31. Zangen DH, Bonner-Weir S, Lee CH, Latimer B, Miller CP, Habener JF, Weir GC: Reduced insulin, GLUT-2 and IDX-1 in β-cells after partial pancreatectomy. Diabetes 46:258-264, 1997
32. Olson LK, Redmon JB, Towle HC, Robertson RP: Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein. J Clin Invest 92:514-519, 1993
33. Koyama M, Wada R, Sakuraba H, Mizukami H, Yagihashi S: Accelerated loss of islet β-cells in sucrose-fed Goto-Kakizaki rats, a genetic model of non-insulin-dependent diabetes mellitus. Am J Pathol 153:537-545, 1398
34. Jonas JC, Sharma A, Hasenkamp W, Ilkova H, Patane G, Laybutt R, Bonner-Weir S, Weir GC: Chronic hyperglycemia triggers loss of pancreatic beta-cell differentiation in an animal model of diabetes. J Biol Chem 274:14112-14121, 1999
35. Donath MY, Gross DJ, Cerasi E, Kaiser N: Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48:738-744, 1999
36. Thorens B: Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc Natl Acad Sci U S A 89:8641-8645, 1992
37. Eng J, Kleinman WA, Singh L, Singh G, Raufman JP: Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom: further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem 267:7402-7405, 1992
38. Scrocchi LA, Brown TJ, MaClusky N, Brubaker PL, Auerbach AB, Joyner AL, Drucker DJ: Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med 2:1254-1258, 1996
39. Scrocchi LA, Marshall BA, Cook SM, Brubaker PL, Drucker DJ: Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling. Diabetes 47:632-639, 1998
40. Zhou J, Wang X, Pineyro MA, Egan JM: Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells. Diabetes 48:2358-2366, 1999
41. Villanueva-Penacarrillo ML, Alcantara AI, Clemente F, Delgado E, Valverde I: Potent glycogenic effect of GLP-1(7-36)amide in rat skeletal muscle. Diabetologia 37:1163-1166, 1994
42. Egan JM, Montrose-Rafizadeh C, Wang Y, Bernier M, Roth J: Glucagon-like peptide-1(7-36) amide (GLP-1) enhances insulin-stimulated glucose metabolism in 3T3-L1 adipocytes: one of several potential extrapancreatic sites of GLP-1 action. Endocrinology 13:2070-2075, 1994
43. Valverde I, Morales M, Clemente F, Lopez-Delgado MI, Delgado E, Perea A, Villanueva-Penacarrillo ML: Glucagon-like peptide 1: a potent glycogenic hormone. FEBS Lett 349: 313-316, 1994.
44. Morales M, Lopez-Delgado MI, Alcantara A, Luque MA, Clemente F, Marquez L, Puente J, Vinambres C, Malaisse WJ, Villanueva-Penacarrillo ML, Valverde I: Preserved GLP-I effects on glycogen synthase a activity and glucose metabolism in isolated hepatocytes and skeletal muscle from diabetic rats. Diabetes 46:1264-1269, 1997
45. Eizirik DL, Sandler S, Welsh N, Hellerstrom C: Preferential reduction of insulin production in mouse pancreatic islets maintained in culture after streptozotocin exposure. Endocrinology 122:1242-1249, 1988
46. Welsh N, Hellerstrom C: In vitro restoration of insulin production in islets from adult rats treated neonatally with streptozotocin. Endocrinology 126:1842-1848, 1990
47. Portha B, Kergoat M: Dynamics of glucose-induced insulin release during the spontaneous remission of streptozotocin diabetes induced in the newborn rats. Diabetes 34:574-579, 1985
48. Finegood DT, Gordon GC, Bonner-Weir S: Prior streptozotocin treatment does not exhibit pancreas regeneration after 90% pancreatectomy in rats. Am J Physiol 276:E822-E827, 1999
49. Bernard C, Thibault C, Berthault MF, Magnan C, Saulnier C, Portha B, Pralong W, Pénicaud L, Ktorza A: Pancreatic β-cell regeneration after 48-h glucose infusion in mildly diabetic rats is not correlated with functional improvement. Diabetes 47:1058-1065, 1998
50. Leahy JL, Bonner-Weir S, Weir GC: Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy. J Clin Invest 81:1407-1414, 1988
51. Tormo MA, Leon-Quinto T, Saulnier C, Bailbe D, Serradas P, Portha B: Insulin secretion and glucose tolerance after islet transplantation in rats with non insulin-dependent diabetes induced by neonatal streptozotocin. Cell Transplant 6:23-32, 1997